Literature DB >> 8603966

Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons.

M T Wong1, M J Dolan, E Kozlow, R Doe, G P Melcher, D S Burke, R N Boswell, M Vahey.   

Abstract

Human immunodeficiency virus (HIV)-1 DNA and RNA levels and T lymphocyte cell surface markers were measured in blood serum and cell fractions from asymptomatic infected patients to find novel virologic and immunologic features in early disease predictive of subsequent clinical disease course. Thirty-two patients with rapid disease progression (rapid CD4+ cell loss and progression to clinical AIDS) were compared with 25 patients with stable infections (constant or rising CD4+ cell counts, no clinical disease manifestations). All HIV-1 burdens measured by polymerase chain reaction were consistently higher in specimens from rapid progressors than slow progressors. For each patient, virus burden remained relatively constant throughout the study period (mean, 42-44 months). Flow cytometry also disclosed stable lymphocyte immunophenotype patterns that correlated strongly with subsequent rapid progression to clinical disease. Thus, in early HIV-1 infection, a constellation of high virus burden and in vivo costimulatory antigen and lymphocyte activation abnormalities is predictive of rapid disease course.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603966     DOI: 10.1093/infdis/173.4.877

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Costimulatory pathways in lymphocyte proliferation induced by the simian immunodeficiency virus SIVsmmPBj14.

Authors:  L Whetter; F J Novembre; M Saucier; S Gummuluru; S Dewhurst
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  Dynamics of hybrid switching DS-I-A epidemic model.

Authors:  Songnan Liu; Daqing Jiang; Xiaojie Xu; Tasawar Hayat; Bashir Ahmad
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

4.  Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay.

Authors:  K Sebire; K McGavin; S Land; T Middleton; C Birch
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Authors:  J R Mascola; M G Lewis; G Stiegler; D Harris; T C VanCott; D Hayes; M K Louder; C R Brown; C V Sapan; S S Frankel; Y Lu; M L Robb; H Katinger; D L Birx
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Sun; J Ku; H Jayakar; J C Kuo; D Brambilla; S Herman; M Rosenstraus; J Spadoro
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.

Authors:  S Wünschmann; J T Stapleton
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

8.  Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.

Authors:  A Trkola; T Ketas; V N Kewalramani; F Endorf; J M Binley; H Katinger; J Robinson; D R Littman; J P Moore
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.

Authors:  P J Blair; J L Riley; D M Harlan; R Abe; D K Tadaki; S C Hoffmann; L White; T Francomano; S J Perfetto; A D Kirk; C H June
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

Review 10.  Modeling methods for estimating HIV incidence: a mathematical review.

Authors:  Xiaodan Sun; Hiroshi Nishiura; Yanni Xiao
Journal:  Theor Biol Med Model       Date:  2020-01-22       Impact factor: 2.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.